More than 50% adults in United states are overweight or obese. Surgery method is invasive and expensive. Allurion Technologies have developed “the procedure-less gastric balloon,” known as the Elipse.
It’s a balloon that goes in the stomach that gives the feeling of fullness, preventing from overeating. A pill attached to a catheter is swallowed. When the coating around the capsule dissolves, the balloon is filled with distilled water. It remains in the stomach for around four months, after which time it deflates and is passed through the user’s stool. No surgery. No endoscopy. No anesthesia.
The balloon has gone through a small human study with 34 patients from Greece and the Czech Republic. In the months the subjects had the Elipse in their stomach, they lost an average of 22 pounds.
Elipse Gastric Balloon has received a CE mark allowing sale of the product in the European Union. This is the company’s first regulatory approval. Elipse™ will initially be available in select leading weight loss centers in France, Italy and the United Kingdom. Elipse™ is not yet approved by the FDA and is not available for sale in the United States.